Alkermes plc

Alkermes plc - PE Ratioverified

ALKS

Price:

$50.38

Market Cap:

$8.45B

Alkermes plc, a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. The company has a portfolio of proprietary commercial products for the treatment of opioid dependence, alcohol dependence, schizophrenia, bipolar I, and a pipeline of clinical and preclinical product candidates in development for neurological disorders. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ARISTADA INITIO for the treatment of schizophrenia in adults; VIVITROL for the treatm...[Read more]

Industry

Biotechnology

IPO Date

1991-07-16

Stock Exchange

NASDAQ

Ticker

ALKS

The PE Ratio as of August 2026 (TTM) for Alkermes plc (ALKS) is 53.03

According to Alkermes plc’s latest financial reports and current stock price. The company's current PE Ratio is 53.03. This represents a change of -95.16% compared to the average of 1.10K of the last 4 quarters.

Alkermes plc (ALKS) Historical PE Ratio (quarterly & annually)

How has ALKS PE Ratio performed in the past?

The mean historical PE Ratio of Alkermes plc over the last ten years is -23.05. The current 53.03 PE Ratio has changed -23102.51% with respect to the historical average. Over the past ten years (40 quarters), ALKS's PE Ratio was at its highest in in the June 2026 quarter at 4.37K. The PE Ratio was at its lowest in in the September 2020 quarter at -5178.13.

Quarterly (TTM)
Annual

Average

-23.05

Median

-27.72

Minimum

-77.53

Maximum

19.03

Alkermes plc (ALKS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Alkermes plc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 172.05%

Maximum Annual PE Ratio = 19.03

Minimum Annual Increase = -148.12%

Minimum Annual PE Ratio = -77.53

Quarterly (TTM)
Annual
YearPE RatioChange
202519.0346.92%
202412.95-0.06%
202312.96-148.12%
2022-26.94-65.26%
2021-77.53172.05%
2020-28.5074.63%
2019-16.32-50.23%
2018-32.79-38.29%
2017-53.1431.93%
2016-40.28-22.88%

Alkermes plc (ALKS) Average PE Ratio

How has ALKS PE Ratio performed in the past?

The current PE Ratio of Alkermes plc (ALKS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

14.98

5-year avg

-11.90

10-year avg

-23.05

Alkermes plc (ALKS) PE Ratio vs. Peers

How is ALKS’s PE Ratio compared to its peers?

Alkermes plc’s PE Ratio is greater than PTC Therapeutics, Inc. (-141.12), greater than Arcellx, Inc. (-28.27), greater than Protagonist Therapeutics, Inc. (-75.73), greater than ACADIA Pharmaceuticals Inc. (12.84), greater than TG Therapeutics, Inc. (16.06), greater than Arrowhead Pharmaceuticals, Inc. (-40.11), greater than Vaxcyte, Inc. (-8.03), greater than CRISPR Therapeutics AG (-11.06), greater than Akero Therapeutics, Inc. (-19.87), greater than Kymera Therapeutics, Inc. (-32.38),

Build a custom stock screener for Alkermes plc (ALKS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alkermes plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Alkermes plc (ALKS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Alkermes plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Alkermes plc's PE Ratio?

How is the PE Ratio calculated for Alkermes plc (ALKS)?

What is the highest PE Ratio for Alkermes plc (ALKS)?

What is the 3-year average PE Ratio for Alkermes plc (ALKS)?

What is the 5-year average PE Ratio for Alkermes plc (ALKS)?

How does the current PE Ratio for Alkermes plc (ALKS) compare to its historical average?